Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
FABm003-05 | Mouse | APC-CY7-Labeled Monoclonal Anti-Human CD8 Antibody, Mouse IgG |
![]() ![]() |
Flow cytometric analysis of Human peripheral blood lymphocytes respectively staining with APC-CY7-Labeled Monoclonal Anti-Human CD8 Antibody Mouse IgG1 (Cat. No. FABm003-05) at 1:20 dilution (5 μL of the antibody stock solution corresponds to labeling of 2.5e5 cells in a final volume of 100 µL), compared with isotype control antibody. APC-CY7 signal was used to evaluate the binding activity (QC tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
89Zr-Df-crefmirlimab | IAB-22-M2C | Phase 3 Clinical | Imaginab Inc | Solid tumours; Skin Melanoma; Carcinoma, Renal Cell; Carcinoma, Merkel Cell; Multiple Sclerosis; Lymphoma; Leukoencephalopathy, Progressive Multifocal; Carcinoma, Non-Small-Cell Lung; Melanoma | Details |
RB-0003 | RB-0003; BNT-111 | Phase 2 Clinical | Biontech Se, Tron | Melanoma | Details |
CD8+ memory T cell therapy (Stanford University) | Phase 2 Clinical | Stanford University | Leukemia; Leukemia, Myelogenous, Chronic; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute | Details | |
GEN-009 | GEN-009 | Phase 2 Clinical | Genocea Biosciences Inc | Skin Melanoma; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung | Details |
VE-800 | VE-800 | Phase 2 Clinical | Vedanta Biosciences Inc | Esophageal Neoplasms; Stomach Neoplasms; Colorectal Neoplasms; Melanoma; Neoplasm Metastasis | Details |
EBViNT Cell (Eutilex) | Phase 2 Clinical | Eutilex | Lymphoma, Extranodal NK-T-Cell | Details | |
ZED88082A | ZED88082A | Phase 2 Clinical | Umcg The University Medical Center Groningen | Neoplasms; Neoplasm Metastasis | Details |
NY-ESO-1-specific autologous CD8+ T-cell therapy (Fred Hutchinson Cancer Research Center) | Phase 1 Clinical | Fred Hutchinson Cancer Research Center, National Cancer Institute | Liposarcoma; Sarcoma, Synovial; Sarcoma | Details | |
MTX-101 (Mozart Therapeutics) | MTX-101 (Mozart Therapeutics) | Phase 1 Clinical | Mozart Therapeutics Inc | Diabetes Mellitus, Type 1; Autoimmune Diseases; Celiac Disease | Details |
Fluorine-18 (18F) CD8-targeted imaging radiopharmaceutical(Ge Healthcare) | GEH200521 (18F); GEH-200521 | Phase 1 Clinical | Ge Healthcare | Solid tumours; Neoplasms | Details |
Tcrx T cell Therapy(Second Affiliated Hospital School Of Zhejiang University School Of Medicine) | Phase 1 Clinical | Second Affiliated Hospital School Of Zhejiang University School Of Medicine | Stomach Neoplasms; Esophageal Neoplasms | Details | |
SCRI-E2CAR_EGFRtv1 | SCRI-E2CAR_EGFRtv1 | Phase 1 Clinical | Umoja BioPharma Inc | Osteosarcoma | Details |
AGX-148 | AGX-148; AGX148 | Phase 1 Clinical | AgonOx Inc | Squamous Cell Carcinoma of Head and Neck; Neoplasms; Colorectal Neoplasms; Genital Neoplasms, Female; Urogenital Neoplasms; Lung Neoplasms; Melanoma | Details |
SNA-006 | 68Ga-NODAGA-SNA006; SNA-006; 68-Ga-NODAGA-SNA-006 | Phase 1 Clinical | Smartnuclide Biopharma | Solid tumours | Details |
AGX-392 | AGX-392 | AgonOx Inc | Details |
This web search service is supported by Google Inc.